ACI’s 6th Annual Summit on Life Sciences IP Due Diligence

Dan Rudoy will speak on a panel titled “Appreciating the Finer Points of IP Due Diligence When the Transaction Involves AI, ML or Platform Technologies” at the American Conference Institute’s 6^th Annual Summit on Life Sciences IP Due Diligence. This two-day summit is devoted to providing corporate and IP counsel with expert strategies for assessing, valuing and commercializing IP assets when conducting strategic IP due diligence which is essential to nearly every corporate transaction.